Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Interest Expenses (2022 - 2025)

Updated

Analysis

Impact Biomedical (IBO) Interest Expenses (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 217.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.59 Mn
Sep 30, 2025 262,000.00
Jun 30, 2025 260,000.00
Mar 31, 2025 271,000.00
Dec 31, 2024 270,000.00
Sep 30, 2024 305,000.00
Jun 30, 2024 261,000.00
Mar 31, 2024 230,000.00
Dec 31, 2023 125,000.00
Sep 30, 2023 102,000.00
Jun 30, 2023 116,000.00
Mar 31, 2023 101,000.00
Dec 31, 2022 99,000.00
Sep 30, 2022 92,000.00
Jun 30, 2022 139,000.00
API Access

Impact Biomedical Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY